About: Responding to SARS-CoV-2 in South Africa: What can we learn from drug-resistant tuberculosis?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Responding to SARS-CoV-2 in South Africa: What can we learn from drug-resistant tuberculosis? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Responding to SARS-CoV-2 in South Africa: What can we learn from drug-resistant tuberculosis?
Creator	Maartens, Gary Hughes, Jennifer Conradie, Francesca Enwerem, Martin Fcpath, Yulene Ferreira, Hannetjie Ismail, Nazir Kock, Kock, Yulene Master, Iqbal Meintjes, Graeme Ndjeka, Norbert Padanilam, Xavier Reuter, Anja Romero, Rodolfo Te Riele, Julian
source	Medline; PMC
abstract	Rapid adoption of new diagnostic tools, parallel process of research and implementation, decentralization of services, the use of personal protective equipment as well as strong partnership and collaboration could strengthen the fight against COVID-19.
has issue date	2020-05-29(xsd:dateTime)
bibo:doi	10.1183/13993003.01369-2020
bibo:pmid	32471936
has license	cc-by-nc
sha1sum (hex)	07d550f614617514b27ab68f36086a1409c5aab2
schema:url	https://doi.org/10.1183/13993003.01369-2020
resource representing a document's title	Responding to SARS-CoV-2 in South Africa: What can we learn from drug-resistant tuberculosis?
has PubMed Central identifier	PMC7257618
has PubMed identifier	32471936
schema:publication	Eur Respir J
resource representing a document's body	covid:07d550f614617514b27ab68f36086a1409c5aab2#body_text
is schema:about of	named entity 'Team' named entity 'Hospital' named entity 'TB treatment' named entity 'coinfection' named entity 'TB treatment' named entity 'Parallel process' named entity 'PPE' named entity 'Death rate' named entity 'COVID' named entity 'HIV' named entity 'diagnostic tools' named entity 'WHO' named entity 'infectious disease' named entity 'death rate' named entity 'personal protective equipment (PPE' named entity 'molecular diagnostic' named entity 'South Africa' named entity 'PPE' named entity 'HIV' named entity 'tuberculosis' named entity 'SARS-CoV-2' named entity 'civil society' named entity 'GeneXpert' named entity 'COVID-19' named entity 'clinical trial' named entity 'polymerase chain reaction' named entity 'non-governmental organizations' named entity 'Bedaquiline' named entity 'public domain' named entity 'clinical guidelines' named entity 'South Africa' named entity 'COVID-19' named entity 'SARS-COV-2' named entity 'infectious disease' named entity 'GeneXpert MTB/RIF' named entity 'tuberculosis control' named entity 'SARS-COV-2' named entity 'clinical trials' named entity 'co-infection' named entity 'nosocomial' named entity 'COVID' named entity 'SARS-COV-2' named entity 'China' named entity 'XDR-TB' named entity 'SARS-COV-2' named entity 'Tuberculosis' named entity 'health care workers' named entity 'South Africa' named entity 'South Africa' named entity 'SARS-CoV-2' named entity 'SARS-COV-2' named entity 'contact tracing' named entity 'personal protective devices' named entity 'COVID' named entity 'SARS-COV-2' named entity 'burden of disease' named entity 'health care workers' named entity 'coronavirus' named entity 'COVID' named entity 'SARS-COV-2' named entity 'adverse events' named entity 'COVID-19' named entity 'contact tracing' named entity 'Northern Cape, South Africa' named entity 'Namakwa' named entity 'SOUTH AFRICA'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software